FOLFOX

FOLFOX Chemotherapy Regimen for Colorectal Cancer

Overview

The FOLFOX chemotherapy regimen is a standard treatment approach for Colorectal Cancer. FOLFOX combines three drugs: Leucovorin (folinic acid), Fluorouracil, and Oxaliplatin. This combination is utilized to enhance the effectiveness and mitigate side effects in the treatment of colorectal cancer. The name "FOLFOX" is derived from the initials of these medications.

FOLFOX chemotherapy drugs

Variations of FOLFOX

FOLFOX regimens come in several variations, each differing in drug dosages and administration methods. The main variations include:

• FOLFOX-4: An earlier version of the regimen, often replaced by newer versions.
• FOLFOX-6: A common and widely used variation.
• Modified FOLFOX-6 (mFOLFOX-6): An adaptation of FOLFOX-6 with adjustments to dosage and schedule for improved tolerability.
• FOLFOX-7: A variation that involves higher doses of oxaliplatin.

Administration

FOLFOX treatment usually involves cycles of administration. Patients receive these drugs intravenously, often in an oncology clinic. The schedule of treatment varies depending on the specific FOLFOX variant prescribed.

Effectiveness and Side Effects

While FOLFOX is effective in many cases, it also has potential side effects. Patients may experience Nausea, fatigue, Neuropathy, and other effects. The severity of side effects can vary based on individual factors and the specific FOLFOX variant used.

External Links

• National Cancer Institute: Drugs Approved for Colorectal Cancer
• American Cancer Society: Chemotherapy for Colorectal Cancer

References

<references/>

• National Center for Biotechnology Information: FOLFOX Regimen in Colorectal Cancer Treatment
• Cancer.Net: Colorectal Cancer - Types of Treatment

• Dailymed label info on FOLFOX
• FDA FOLFOX